Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)

SHA:603983 Revenue

Guangdong Marubi Biotechnology had revenue of 781.79M CNY in the quarter ending June 30, 2026, a decrease of -14.84%. This brings the company's total for the last twelve months to 3.36B, down -0.72% year-over-year. In the year 2025, Guangdong Marubi Biotechnology had annual revenue of 3.46B with 16.48% growth. That makes Guangdong Marubi Biotechnology the 11,206th largest company in the world by revenue and 1,880th in China.

• Revenue (ttm): 3.36B
• Revenue Growth: -0.72%
• P/S Ratio: 2.96
• Revenue / Employee: 2.43M
• Employees: 1,380
• Market Cap: 9.70B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.46B	489.55M	16.48%
Dec 31, 2024	2.97B	744.18M	33.44%
Dec 31, 2023	2.23B	493.88M	28.52%
Dec 31, 2022	1.73B	-55.31M	-3.10%
Dec 31, 2021	1.79B	42.04M	2.41%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error